Refreshing results…
Treatment response score to glatiramer acetate or interferon beta-1a
UploadFirst therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study
UploadRadiologically Isolated Syndrome: 10‐Year Risk Estimate of a Clinical Event
UploadTreatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience
Download from journals.sagepub.comLifespan normative data on rates of brain volume changes
UploadExtending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
UploadMissing publications? Search for publications with a matching author name.